Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 7
Results: 9
Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 737, doi. 10.1007/s00262-014-1552-9
- By:
- Publication type:
- Article
miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 699, doi. 10.1007/s00262-014-1550-y
- By:
- Publication type:
- Article
Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 663, doi. 10.1007/s00262-014-1546-7
- By:
- Publication type:
- Article
Monitoring the immune competence of cancer patients to predict outcome.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 713, doi. 10.1007/s00262-014-1521-3
- By:
- Publication type:
- Article
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 675, doi. 10.1007/s00262-014-1545-8
- By:
- Publication type:
- Article
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 685, doi. 10.1007/s00262-014-1548-5
- By:
- Publication type:
- Article
Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
- Published in:
- 2014
- By:
- Publication type:
- Report
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 721, doi. 10.1007/s00262-014-1549-4
- By:
- Publication type:
- Article
Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 7, p. 643, doi. 10.1007/s00262-014-1544-9
- By:
- Publication type:
- Article